tolazamide has been researched along with chlorpropamide in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 41 (74.55) | 18.7374 |
1990's | 3 (5.45) | 18.2507 |
2000's | 4 (7.27) | 29.6817 |
2010's | 6 (10.91) | 24.3611 |
2020's | 1 (1.82) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Anacardio, R; Aureli, L; Cesta, MC; Cruciani, G; De Simone, L; Moriconi, A | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Coulson, R; Moses, AM | 1 |
Bressler, R; Shen, SW | 1 |
Friedberg, SJ; Kudzma, DJ | 1 |
Milman, HA; Peckham, JC; Tarone, RE; Ward, JM | 1 |
Field, JB; Schmeltz, R; Wendorff, HJ | 1 |
Bullock, I; Galloway, DB; Gilbert, JC; Petrie, JC; Watson, WA | 1 |
Bohannon, NV; Dunphy, TW; Forsham, PH; Gerich, JE; Kane, JP; Karam, JH; Lorenzi, M; Tsalikian, E | 1 |
Friedberg, SJ; Pugh, JA; Ramirez, G; Sawyer, J; Tuley, M; Wagner, ML | 1 |
Franz, CB; Massullo, RE; Welton, WA | 1 |
Burns, EA; Perry, PJ; True, BL | 1 |
Davis, FB; Davis, PJ; Edwards, L; Van Son, A | 1 |
Gelb, AM; Nakao, NL; Siegel, JH; Stenger, RJ | 1 |
Brown, KF; Crooks, MJ | 1 |
Stowers, JM | 1 |
de Baere, H; de Leeuw, I; Decraene, P; Lemmens, P; Verhaegen, H | 1 |
Scoville, AB | 1 |
Lasseter, KC; Levey, GS; McCarthy, JS; Palmer, RF | 1 |
Stehling, L | 1 |
Howanitz, J; Miller, M; Moses, AM | 1 |
DeLawter, DE; Moss, JM | 1 |
Mulder, G; Thurkow, I; Wesseling, H | 1 |
Aggarwal, V; Sunshine, I | 1 |
Loubatières, AL | 1 |
Borden, K; Hearron, M; Novak, E; Vitti, T | 1 |
Jackson, WP | 1 |
Bricker, LA; Mintz, DH | 1 |
Bressler, R; Sherwood, G | 1 |
Meijer, DK; Thürkow, I; Wesseling, H | 1 |
Harris, EL | 1 |
Garcia, M; Miller, M; Moses, AM | 1 |
Ando, A; Orita, Y; Shirai, D; Takamitsu, Y; Urakabe, S | 1 |
Sussman, KE | 1 |
Barnett, JH; Barnett, SM | 1 |
Feldman, JM; Skillman, TG | 1 |
Kreider, RM; Luderer, JR; Sloan, RW | 1 |
Boden, G; Gordon, SS; Master, RW; Owen, OE; Shuman, CR | 1 |
Bridges, ME; Pittman, FE | 1 |
Selvaag, E | 1 |
DALLECOSTE, P; KLINGER, R | 1 |
BARSE, R; GRINNELL, EH; MOLLER, CL; SKILLMAN, TG | 1 |
MARQUES, M; RIETCORREA, P | 1 |
FORIST, AA; SMITH, DL; VECCHIO, TJ | 1 |
Jannetto, PJ; Langman, LJ | 1 |
8 review(s) available for tolazamide and chlorpropamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of oral antidiabetic agents (first of two parts).
Topics: Acetohexamide; Administration, Oral; Chemical Phenomena; Chemistry; Chlorpropamide; Diabetes Mellitus; Drug Evaluation; Drug Interactions; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Lipid Metabolism; Phenformin; Secretory Rate; Tolazamide; Tolbutamide | 1977 |
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
Oral treatment in diabetes.
Topics: Acetohexamide; Acidosis; Administration, Oral; Animals; Biguanides; Cardiovascular Diseases; Chlorpropamide; Diabetes Complications; Diabetes Mellitus; Glyburide; Humans; Hypoglycemia; Liver; Obesity; Structure-Activity Relationship; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1972 |
Hypoglycemic drugs.
Topics: Acetohexamide; Anesthetics; Blood Glucose; Carbohydrate Metabolism; Chlorpropamide; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Gastrointestinal Diseases; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Pancreas; Phenformin; Tolazamide; Tolbutamide | 1974 |
[Hypoglycemic sulfonamides].
Topics: Acetohexamide; Animals; Blood Glucose; Carbutamide; Chlorpropamide; Dogs; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Organ Size; Pancreas; Rats; Stimulation, Chemical; Sulfonamides; Tolazamide; Tolbutamide | 1968 |
Oral sulphonylureas in the management of diabetes.
Topics: Acetohexamide; Chlorpropamide; Cyclohexanes; Diabetes Mellitus; Endocrine Glands; Glucose Tolerance Test; Humans; Hypoglycemia; Hypoglycemic Agents; Obesity; Pyrimidines; Sulfones; Sulfonic Acids; Tolazamide; Tolbutamide; Urea; Vascular Diseases | 1971 |
Insulin-independent diabetes mellitus.
Topics: Acetohexamide; Adult; Age Factors; Aged; Basement Membrane; Capillaries; Carbohydrate Metabolism, Inborn Errors; Chlorpropamide; Diabetes Complications; Diabetes Mellitus; Diet, Diabetic; Female; Glucose Tolerance Test; Humans; Hyperlipidemias; Hypoglycemic Agents; Infections; Male; Middle Aged; Muscles; Obesity; Phenformin; Skin Ulcer; Thigh; Tolazamide; Tolbutamide | 1971 |
4 trial(s) available for tolazamide and chlorpropamide
Article | Year |
---|---|
Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
Topics: Blood Glucose; Chlorpropamide; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus; Drug Synergism; Glycolates; Halofenate; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Phenformin; Tolazamide; Tolbutamide | 1977 |
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
Blood glucose and drug levels in normal fasting subjects following single oral doses of tolazamide and chlorpropamide.
Topics: Blood Glucose; Chlorpropamide; Clinical Trials as Topic; Humans; Hypoglycemic Agents; Male; Time Factors; Tolazamide | 1969 |
Comparision of chlorpropamide with tolazamide in the treatment of diabetes mellitus.
Topics: Chlorpropamide; Diabetes Mellitus; Humans; Hypoglycemic Agents; Tolazamide; Urea | 1968 |
44 other study(ies) available for tolazamide and chlorpropamide
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Chemical Phenomena; Chemistry, Physical; Humans; In Vitro Techniques; Interleukin-8; Models, Molecular; Phenylpropionates; Protein Binding; Quantitative Structure-Activity Relationship; Serum Albumin; Stereoisomerism | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism.
Topics: Adult; Animals; Chlorpropamide; Cyclic AMP; Female; Humans; Hypoparathyroidism; Kidney; Male; Parathyroid Glands; Parathyroid Hormone; Phosphates; Pseudohypoparathyroidism; Rats; Tolazamide | 1975 |
Reduction of the severity of nephropathy in aging Fischer 344 rats treated with analogs of arylsulfonyluria.
Topics: Acetohexamide; Animals; Chlorpropamide; Female; Hypoglycemic Agents; Kidney Diseases; Male; Phenformin; Rats; Rats, Inbred F344; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1979 |
Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
Topics: Adult; Aged; Blood Glucose; Chlorpropamide; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Tolazamide; Tolbutamide | 1978 |
In vivo cytogenetic activity of sulphonylurea drugs in man.
Topics: Adult; Chlorpropamide; Chromosome Aberrations; Chromosome Deletion; Diabetes Mellitus; Female; Glyburide; Humans; Lymphocytes; Male; Middle Aged; Pregnancy; Sulfonylurea Compounds; Tolazamide; Translocation, Genetic | 1976 |
The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.
Topics: Acetohexamide; Administration, Oral; Adult; Aged; Chlorpropamide; Diabetes Mellitus; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Phenformin; Time Factors; Tolazamide; Tolbutamide | 1977 |
Lichenoid drug eruption from chlorpropamide and tolazamide.
Topics: Aged; Chlorpropamide; Drug Eruptions; Drug Hypersensitivity; Humans; Leg; Lichen Planus; Male; Tolazamide | 1990 |
Profound hypoglycemia with the addition of a tricyclic antidepressant to maintenance sulfonylurea therapy.
Topics: Aged; Chlorpropamide; Depressive Disorder; Diabetes Complications; Diabetes Mellitus; Doxepin; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypoglycemia; Middle Aged; Nortriptyline; Tolazamide | 1987 |
Urinary diluting capacity in elderly diabetic subjects.
Topics: Aged; Aging; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney Concentrating Ability; Male; Middle Aged; Sulfonylurea Compounds; Tolazamide; Water; Water-Electrolyte Balance | 1986 |
A case of chronic liver disease due to tolazamide.
Topics: Aged; Chemical and Drug Induced Liver Injury; Chlorpropamide; Diabetes Mellitus; Female; Humans; Jaundice; Tolazamide | 1985 |
The binding of sulphonylureas to serum albumin.
Topics: Animals; Carbon Radioisotopes; Cattle; Chlorpropamide; Glyburide; Humans; Hydrogen-Ion Concentration; Protein Binding; Serum Albumin; Serum Albumin, Bovine; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1974 |
[Hypoglycemia caused by oral antidiabetic agents].
Topics: Adult; Aged; Chlorpropamide; Delayed-Action Preparations; Diet; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Kidney Diseases; Liver Diseases; Male; Middle Aged; Phenformin; Tolazamide; Tolbutamide | 1973 |
Editorial: Oral therapy in diabetes mellitus.
Topics: Acetohexamide; Biguanides; Chlorpropamide; Diabetes Mellitus; Diabetic Ketoacidosis; Diet Therapy; Humans; Hypoglycemia; Hypoglycemic Agents; Lactates; Phenformin; Placebos; Pyruvates; Sulfonylurea Compounds; Tolazamide; Tolbutamide; Typhoid Fever | 1974 |
The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinje fiber automaticity, and adenyl cyclase activity from rabbit and human hearts.
Topics: Acetohexamide; Adenylyl Cyclases; Animals; Chlorpropamide; Culture Techniques; Cyclic AMP; Dogs; Heart; Heart Atria; Heart Conduction System; Humans; Membrane Potentials; Microelectrodes; Myocardium; Phenformin; Propranolol; Rabbits; Stimulation, Chemical; Sulfonylurea Compounds; Theophylline; Tolazamide; Tolbutamide | 1972 |
Diabetes mellitus: the thin maturity-onset diabetic.
Topics: Acetohexamide; Body Weight; Chlorpropamide; Diabetes Mellitus; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Tolazamide; Tolbutamide | 1972 |
Diuretic action of three sulfonylurea drugs.
Topics: 11-Hydroxycorticosteroids; Acetohexamide; Adrenal Glands; Adult; Autoanalysis; Blood Glucose; Chlorpropamide; Creatinine; Diuresis; Evaluation Studies as Topic; Glyburide; Humans; Male; Natriuresis; Photometry; Potassium; Radioimmunoassay; Tolazamide; Vasopressins; Water | 1973 |
Long-term results with oral hypoglycemic drugs.
Topics: Acetohexamide; Adult; Aged; Blood Glucose; Chlorpropamide; Diabetes Mellitus; Diet, Diabetic; Humans; Longevity; Middle Aged; Phenformin; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1973 |
Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
Topics: Animals; Brain; Carbon Radioisotopes; Chlorpropamide; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Half-Life; Hydroxylation; In Vitro Techniques; Liver; Male; Phenytoin; Rats; Time Factors; Tolazamide; Tolbutamide | 1973 |
Determination of sulfonylureas and metabolites by pyrolysis gas chromatography.
Topics: Amobarbital; Chlorobenzenes; Chlorpropamide; Chromatography, Gas; Evaluation Studies as Topic; Humans; Mass Spectrometry; Methods; Pentobarbital; Phenobarbital; Secobarbital; Structure-Activity Relationship; Sulfonamides; Sulfonylurea Compounds; Time Factors; Tolazamide; Tolbutamide | 1974 |
Estimation of phenytoin in body fluids in the presence of sulphonyl urea compounds.
Topics: Animals; Benzophenones; Body Fluids; Brain Chemistry; Chlorpropamide; Methods; Phenytoin; Potassium Permanganate; Rats; Spectrophotometry; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1972 |
Adverse reactions to oral antidiabetic agents.
Topics: Acetohexamide; Acidosis; Administration, Oral; Anemia; Chlorpropamide; Drug Antagonism; Drug Synergism; England; Ethanol; Female; Fetus; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Metformin; Phenformin; Pregnancy; Scotland; Skin Diseases; Skin Manifestations; Tolazamide; Tolbutamide; Wales | 1971 |
Chlorpropamide-induced water retention in patients with diabetes mellitus.
Topics: Aged; Chlorpropamide; Diabetes Mellitus; Female; Humans; Hyponatremia; Kidney Tubules; Male; Tolazamide; Vasopressins; Water Intoxication | 1971 |
Status of problem of usage of tolbutamide. Preliminary statements.
Topics: Acetohexamide; Chlorpropamide; Diabetes Mellitus; Diet Therapy; Humans; Tolazamide; Tolbutamide; United States; United States Food and Drug Administration | 1970 |
A quantum chemical study with special reference to the sulfamyl group of sulfonylureas.
Topics: Acetohexamide; Carbutamide; Chlorpropamide; Humans; Hypoglycemic Agents; Quantum Theory; Sulfones; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1970 |
The use and abuse of oral hypoglycemic agents.
Topics: Acetohexamide; Biguanides; Chlorpropamide; Humans; Hypoglycemic Agents; Tolazamide; Tolbutamide | 1967 |
Lichenoid drug reactions to chlorpropamide and tolazamide.
Topics: Aged; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Eruptions; Humans; Lichen Planus; Male; Tolazamide | 1984 |
The pharmacology of sulfonylureas.
Topics: Acetohexamide; Blood Glucose; Chlorpropamide; Diabetes Mellitus; Glyburide; Humans; Insulin; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1981 |
The effect of chlorpropamide hyponatremia on mental status in a nursing home population.
Topics: Aged; Chlorpropamide; Humans; Hyponatremia; Mental Disorders; Nursing Homes; Tolazamide | 1983 |
Monitoring metabolic control in diabetic outpatients with glycosylated hemoglobin.
Topics: Administration, Oral; Aged; Ambulatory Care; Blood Glucose; Chlorpropamide; Diabetes Mellitus; Fasting; Female; Hemoglobin A; Humans; Hypoglycemic Agents; Male; Middle Aged; Time Factors; Tolazamide | 1980 |
Tolazamide-induced cholestasis.
Topics: Chlorpropamide; Cholestasis, Intrahepatic; Female; Humans; Liver; Middle Aged; Tolazamide | 1980 |
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E | 1996 |
[ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
Topics: Carbutamide; Chlorpropamide; Diabetes Mellitus; Drug Tolerance; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1964 |
CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
Topics: Biomedical Research; Blood Glucose; Chemical Phenomena; Chemistry; Chlorpropamide; Diabetes Mellitus; Drug Therapy; Humans; Hypoglycemic Agents; Insulin; Pharmacology; Sulfonylurea Compounds; Tolazamide; Tolbutamide; Toxicology | 1964 |
[ACTION OF HYPOGLYCEMIC SULFONAMIDES ON THE PRODUCTION OF CO2 BY ADIPOSE TISSUE OF THE RAT EPIDIDYMIS "IN VITRO"].
Topics: Acetohexamide; Adipose Tissue; Carbon Dioxide; Carbutamide; Chlorpropamide; Epididymis; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Male; Metabolism; Pharmacology; Rats; Research; Sulfanilamide; Sulfanilamides; Sulfonamides; Tolazamide; Tolbutamide | 1964 |
METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
Topics: Acetohexamide; Biological Transport; Blood; Chlorpropamide; Fluids and Secretions; Humans; Hypoglycemic Agents; Metabolism; Sulfonylurea Compounds; Tolazamide; Tolbutamide; Urine | 1965 |
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide | 2024 |